C
Green Thumb Industries Inc. GTBIF
$7.62 $0.060.79% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Green Thumb Industries Inc. is a U.S.-based cannabis consumer packaged goods company that operates across the regulated medical and adult-use cannabis industries. The company cultivates, manufactures, distributes, and retails cannabis products through a vertically integrated operating model. Its primary revenue drivers include retail cannabis sales through its RISE Dispensaries chain, branded packaged cannabis products, and wholesale distribution to third-party dispensaries. Green Thumb markets products across multiple categories including flower, vapes, edibles, concentrates, pre-rolls, and wellness-oriented cannabis products under brands such as RYTHM, Dogwalkers, Incredibles, Beboe, and Dr. Solomon’s.

Founded in 2014 and headquartered in Chicago, Illinois, Green Thumb expanded through acquisitions, cultivation facility development, and state-by-state licensing opportunities in regulated U.S. cannabis markets. The company is publicly traded in Canada and over-the-counter in the United States under the ticker GTBIF. Its strategic positioning has centered on operating in limited-license states, maintaining vertical integration, and building nationally recognized cannabis consumer brands within a fragmented regulatory environment.

Business Operations

Green Thumb organizes its operations primarily through two core business channels: retail operations and consumer packaged goods manufacturing. The company operates RISE Dispensaries across multiple U.S. states and also supplies products to third-party retailers through wholesale distribution. Revenue is generated from direct-to-consumer retail sales, branded product sales, and wholesale cannabis distribution. Its operations include cultivation facilities, manufacturing and processing sites, and retail dispensaries licensed under varying state regulatory structures.

The company maintains operations in both medical and adult-use cannabis markets across the United States, with a concentration in states such as Illinois, Pennsylvania, New Jersey, Nevada, Massachusetts, and Florida. Green Thumb controls cultivation, extraction, packaging, and retail infrastructure in several jurisdictions, allowing operational integration from production to consumer sale. The company has also developed strategic relationships with state regulators, licensing partners, and local operators as part of its expansion model. Public filings and investor materials identify vertically integrated assets and branded product distribution as central operational strengths.

Strategic Position & Investments

Green Thumb’s strategic direction has focused on disciplined expansion in limited-license states, operational profitability, and long-term brand development within the U.S. cannabis sector. The company has historically emphasized cash flow generation and selective capital allocation compared with some industry peers that pursued more aggressive acquisition-driven growth. Major investments have included cultivation capacity expansion, retail footprint growth, and manufacturing infrastructure to support branded product distribution.

The company has completed acquisitions and market-entry transactions in several regulated states to strengthen its operational footprint and license portfolio. Its portfolio includes recognized cannabis brands such as Dogwalkers, RYTHM, Good Green, and Incredibles, which are positioned across premium, mainstream, and value-oriented product segments. Green Thumb has also invested in consumer-facing retail experiences and product innovation in areas including cannabis wellness, edibles, and vaporization products. Public disclosures indicate continued interest in expansion opportunities tied to evolving U.S. cannabis legalization trends and state-level regulatory developments.

Geographic Footprint

Green Thumb operates exclusively within the United States, with a multi-state presence spanning key regulated cannabis markets. The company’s headquarters are located in Chicago, Illinois, and its operations extend across numerous states with both medical and adult-use cannabis programs. Major operating regions include the Midwest, Northeast, Southeast, and Western United States, with cultivation, manufacturing, and retail assets distributed according to state licensing frameworks.

The company’s retail and production footprint has included operations in states such as Illinois, Pennsylvania, New Jersey, New York, Ohio, Virginia, Maryland, Massachusetts, Minnesota, Nevada, and Florida. Because U.S. federal law continues to classify cannabis as a controlled substance, Green Thumb’s activities remain domestically focused rather than internationally operational. However, the company is considered one of the larger U.S. multi-state cannabis operators by revenue and retail scale based on publicly available market data and company disclosures.

Leadership & Governance

Green Thumb was founded by Ben Kovler, who has played a central role in shaping the company’s long-term strategy and regulatory positioning within the U.S. cannabis industry. Leadership has consistently emphasized disciplined growth, operational efficiency, consumer brand development, and regulatory compliance. Company governance and operational reporting are outlined in public filings including annual reports and Canadian securities disclosures.

Key executives include:

  • Ben Kovler – Chairman and Chief Executive Officer
  • Anthony Georgiadis – Chief Financial Officer
  • Pete Kadens – Co-Founder and Former Executive Chairman
  • Richard Batenburg – Former Chief Financial Officer
  • Matt Faulkner – Senior Vice President, Consumer Packaged Goods
  • Jennifer Dooley – Chief Strategy Officer

Public disclosures indicate that Green Thumb’s leadership philosophy prioritizes sustainable expansion, profitability, and long-term positioning in anticipation of broader cannabis market normalization in the United States. Some executive role information may change over time due to organizational updates; where recent changes could not be fully verified across multiple public sources, data remains inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $217.55
B
AAPL NASDAQ $319.70
B
AVGO NASDAQ $368.79
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $103.09
Top Financial Stocks
See All »
B
B
JPM NYSE $357.62
B
V NYSE $381.60
Top Health Care Stocks
See All »
B
LLY NYSE $1,174.61
B
JNJ NYSE $268.04
B
ABBV NYSE $255.48
Top Real Estate Stocks
See All »
B
PLD NYSE $140.70
B
EQIX NASDAQ $1,044.41